Ryan Specialty Holdings, Inc. (RYAN) SEC Filings & Earnings Calls
EquiReason read 14 Ryan Specialty Holdings, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-07 — Ryan Specialty Holdings entered an amendment to an executive chairman option settlement agreement to extend back-to-back purchase arrangement for compensatory stock options, net ne.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 11.2B
- P/E TTM
- 46.2
- Dividend yield
- 0.6%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
31 Jul 202610-QRyan Specialty reported Q2 2026 results with total revenue +7.2% YoY, organic growth 6.7%, GAAP net income -13.1% due to restructuring costs, but adjusted diluted EPS +12.1%.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q2-2026 | $917M | +7% y/y |
| Net income · Q2-2026 | $108M | -13% y/y |
| Organic revenue growth rate · Q2-2026 | 6.7% | |
| Adjusted EBITDAC · Q2-2026 | $327M | +6% y/y |
| Adjusted diluted earnings per share · Q2-2026 | $0.74 | +12% y/y |
| Headcount · 2026-06-30 | 6,171 | +8% y/y |
Risks flagged
Property rate decline and direct placement shift
“We experienced growth across the majority of our casualty lines offset by a moderate pullback across our property portfolio driven by a continued decline in rates and retailers realizing additional opportunities to place coverage directly.” · word for word
Restructuring execution risk
“The program is estimated to result in approximately $160 million of cumulative one-time charges through 2028... changes to the total savings estimate and timing of the Empower Program may evolve as we continue to progress through the program.” · word for word
30 Jul 20268-K · 2.02, 8.01Ryan Specialty reported Q2 2026 revenue of $916.6M (+7.2% YoY), organic growth 6.7%, Adj. EBITDAC $326.9M (+6.0%), Adj. diluted EPS $0.74 (+12.1%). Guidance: mid-single-digit organic revenue growth; Adj. EBITDAC margin down 50-100 bps YoY.earningsopen
Figures in the filing · each found in the filing text
| Total Revenue · Q2-2026 | $917M | +7% y/y |
| Organic Revenue Growth Rate · Q2-2026 | 6.7% | |
| Net Income · Q2-2026 | $108M | -13% y/y |
| Adjusted EBITDAC · Q2-2026 | $327M | +6% y/y |
| Adjusted Net Income · Q2-2026 | $199M | +8% y/y |
| Adjusted Diluted EPS · Q2-2026 | $0.74 | +12% y/y |
| Share Repurchases · Q2-2026 | $260M | |
| Dividends and Distributions · Q2-2026 | $25M |
Risks flagged
Challenging environment: management notes 'very challenging environment' but still delivered growth.
“We are proud of our excellent second quarter performance, especially given the very challenging environment” · word for word
1 May 202610-QTotal revenue $795M (+15% y/y); Net commissions and fees $783M (+16% y/y); Organic revenue growth rate 11.8open
Figures in the filing · each found in the filing text
| Total revenue · Q1-2026 | $795M | +15% y/y |
| Net commissions and fees · Q1-2026 | $783M | +16% y/y |
| Organic revenue growth rate · Q1-2026 | 11.8% | |
| Adjusted EBITDAC · Q1-2026 | $232M | +16% y/y |
| Adjusted EBITDAC margin · Q1-2026 | 29.2% | |
| Adjusted net income · Q1-2026 | $131M | +21% y/y |
| Adjusted diluted earnings per share · Q1-2026 | $0.47 | +21% y/y |
| Net income (loss) · Q1-2026 | $41M |
Risks flagged
Property rate decline headwind
“Beginning in the second half of 2024 and through the first quarter of 2026, the specialty and E&S markets experienced a shift in these trends as insurance capacity for these property risks increased, which resulted in a decline in property premium rates.” · word for word
Restructuring execution risk
“The program is estimated to result in approximately $160 million of cumulative one-time charges through 2028, funded through operating cash flow, and is expected to generate annual savings of approximately $80 million in 2029.” · word for word
17 Mar 2026DEF 14AAnnual proxy statement disclosing executive compensation, governance changes, and strong 2025 financial results.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $3.00B | +21% y/y |
| Organic Revenue Growth Rate · FY2025 | 10.1% | |
| Adjusted EBITDAC Margin · FY2025 | 31.0% | |
| Net Income · FY2025 | $214M | |
| Total Stockholder Return (TSR) · FY2025 | $191.00 | |
| Share Repurchase Authorization · 2026-03-17 | $300M | |
| Dividend Increase · 2026-03-17 | 8.0% |
Guidance
Inaugural $300M buyback authorization; 8% dividend increase
Management expresses strong confidence in near- and long-term outlook, supported by buyback and dividend increase, but margin remains under pressure.
Risks flagged
Margin Pressure from Restructuring
“Adjusted EBITDAC Margin was 30.97%, below the target range, indicating margin pressure despite revenue growth.”
Integration Risk from M&A
“Over the last two years, we've invested nearly $2.7 billion in 12 acquisitions, significantly diversifying our platform with new products, geographies, and capabilities.” · word for word
Key Person Dependency
“Patrick G. Ryan, founder and Executive Chairman, holds 77.1% combined voting power, creating concentration risk.” · word for word
13 Feb 202610-KAdjusted diluted earnings per share $1.96 (+10% y/y); Organic revenue growth 10.1; Producer retention rate 96open
Figures in the filing · each found in the filing text
| Adjusted diluted earnings per share · FY2025 | $1.96 | +10% y/y |
| Organic revenue growth · FY2025 | 10.1% | |
| Producer retention rate · FY2025 | 96.0% | |
| Wholesale Brokerage net commission and fees · Wholesale Brokerage · FY2025 | $1.60B | |
| Binding Authority net commission and fees · Binding Authority · FY2025 | $370M | |
| Underwriting Management net commission and fees · Underwriting Management · FY2025 | $1.02B | +59% y/y |
| Diluted earnings per share · FY2025 | $0.47 | -34% y/y |
| Total employees · 2025-12-31 | 6,110 | |
| Number of offices · 2025-12-31 | 129 |
Guidance
Management expresses confidence in continued E&S market growth and Ryan Specialty's competitive position, but provides no specific numerical guidance.
Risks flagged
Acquisition integration risk
“We have previously made, and intend to continue to pursue, acquisitions with the objective of enhancing our human capital, product capabilities, natural adjacencies, and geographic footprint.” · word for word
Key person dependency
“our failure to successfully recruit and retain our senior management team, revenue producers, or other key employees” · word for word
12 Feb 20268-K · 2.02, 2.05, 7.01, 8.01Released earnings results and quarterly financials; approved costs associated with restructuring, layoffs, or exit activitiesearningsopen
Risks flagged
Restructuring with $160M charges indicates significant operational changes and potential disruption.
“Empower Program with $160M cumulative pre-tax charges.”
8 Dec 20258-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Loss of board member with significant industry experience; but orderly and mutually agreed.
“Retirement by mutual agreement; no disagreement; Onex sold its remaining shares.”
31 Oct 202510-QRyan Specialty reported strong Q3 2025 results with 24.8% revenue growth, 15.0% organic growth, and 118.6% net income increase.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q3-2025 | $755M | +25% y/y |
| Net commissions and fees · Q3-2025 | $740M | +26% y/y |
| Organic revenue growth rate · Q3-2025 | 15.0% | |
| Adjusted EBITDAC · Q3-2025 | $236M | +24% y/y |
| Adjusted EBITDAC margin · Q3-2025 | 31.2% | |
| Adjusted diluted earnings per share · Q3-2025 | $0.47 | +15% y/y |
| Net income · Q3-2025 | $63M | +119% y/y |
| Compensation and benefits expense ratio · Q3-2025 | 58.4% | |
| Headcount · 2025-09-30 | 5,982 | +22% y/y |
Risks flagged
Property rate decline
“In the second half of 2024 and through the first nine months of 2025, the specialty and E&S markets experienced a shift in these trends as insurance capacity for these property risks increased, which resulted in a decline in property premium rates.” · word for word
Integration risk from acquisitions
“Our ability to successfully pursue strategic acquisitions is dependent upon a number of factors, including sustained execution of a disciplined and selective acquisition strategy.” · word for word
Interest expense increase
“Interest expense, net increased $59.3 million, or 53.9%, from $109.9 million to $169.2 million for the nine months ended September 30, 2025.” · word for word
30 Oct 20258-K · 2.02, 8.01Total revenue $755M (+25% y/y); Organic Revenue Growth Rate 15; Net income $63M (+119% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q3-2025 | $755M | +25% y/y |
| Organic Revenue Growth Rate · Q3-2025 | 15.0% | |
| Net income · Q3-2025 | $63M | +119% y/y |
| Adjusted EBITDAC · Q3-2025 | $236M | +24% y/y |
| Adjusted EBITDAC Margin · Q3-2025 | 31.2% | |
| Adjusted Net Income · Q3-2025 | $132M | +16% y/y |
| Adjusted Diluted Earnings Per Share · Q3-2025 | $0.47 | +15% y/y |
| Diluted Earnings Per Share · Q3-2025 | $0.20 | |
| Net commissions and fees · Q3-2025 | $740M | +26% y/y |
| Operating income · Q3-2025 | $111M | +36% y/y |
Risks flagged
Margin pressure from strategic investments in talent and technology
“Adjusted EBITDAC Margin decreased from 31.5% to 31.2% due to investments”
General and administrative expenses grew 32.6% YoY, outpacing revenue growth
“General and administrative 117,589 88,684 28,905 32.6%” · word for word
Ryan Specialty Holdings, Inc. — questions
- What did Ryan Specialty Holdings, Inc. file recently?
- 14 SEC filings in the last 12 months. Latest: 8-K on 2026-08-07 — Ryan Specialty Holdings entered an amendment to an executive chairman option settlement agreement to extend back-to-back purchase arrangement for compensatory stock options, net neutral to share count.
Every figure on this page comes from Ryan Specialty Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.